Use Of An Antibody Or An Immunotoxin That Selectively Binds To Cd123 To Impair Hematologic Cancer Progenitor Cells

Patent No. EP2329847 (titled "Use Of An Antibody Or An Immunotoxin That Selectively Binds To Cd123 To Impair Hematologic Cancer Progenitor Cells") was filed by University OF Kentucky Research Foundation on Mar 6, 2001. The application was issued on Nov 2, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JANSSEN BIOTECHAug 2, 2017VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
CSLAug 1, 2017WISE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2329847

UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Application Number
EP10183896A
Filing Date
Mar 6, 2001
Status
Revoked
Mar 12, 2021
Publication Date
Nov 2, 2016